Rote-Hand-Brief: Respreeza (humaner Alpha-1-Proteinase-Inhibitor)

Paul-Ehrlich-Institut Version 1 original current

Imported from official source

Risiko einer Dosisauslassung und potenzieller Infektionen aufgrund einer beeinträchtigten Integrität des Primärbehältnisses

This version

Version
1 of 1
Recorded
October 30, 2026 11:30
Change
Initial
Content hash
b5e8a73a5940de0c588cbd61cb998f70
All versions
Revision history

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.